Immunizations in patients with inflammatory bowel disease

Inflammatory Bowel Diseases

Volumn 15, Issue 9, 2009, Pages 1417-1423

  Lu, Ying ^a   Jacobson, Denise ^a   Bousvaros, Athos ^a  

^a BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

6 mercaptopurine; Azathioprine; Crohn's disease; Immunization; Immunosuppression; Inflammatory bowel disease; Infliximab; Opportunistic infection; Tumor necrosis factor inhibitor; Ulcerative colitis; Vaccine

Indexed keywords

CALCINEURIN INHIBITOR; CASPASE RECRUITMENT DOMAIN PROTEIN 15; CHICKENPOX VACCINE; CORTICOSTEROID; CYCLOSPORIN; IMMUNOMODULATING AGENT; INACTIVATED VACCINE; INFLIXIMAB; INFLUENZA VACCINE; INTERLEUKIN 13; INTERLEUKIN 18; INTERLEUKIN 23 RECEPTOR; LIVE VACCINE; PLACEBO; PNEUMOCOCCUS VACCINE; RAPAMYCIN; TACROLIMUS; TETANUS TOXOID; TUMOR NECROSIS FACTOR ALPHA INHIBITOR; TUMOR NECROSIS FACTOR INHIBITOR; VACCINE;

ADAPTIVE IMMUNITY; ANTIBODY RESPONSE; ANTIBODY TITER; APOPTOSIS; CD4 LYMPHOCYTE COUNT; CD4+ T LYMPHOCYTE; CELL CYCLE; CLINICAL TRIAL; CLOSTRIDIUM DIFFICILE INFECTION; DRUG EFFICACY; DRUG SAFETY; ENTERITIS; GENE MUTATION; HEPATITIS B; HUMAN; IMMUNIZATION; IMMUNOCOMPROMISED PATIENT; IMMUNOGENICITY; IMMUNOSUPPRESSIVE TREATMENT; INFECTION RISK; INFLUENZA; INNATE IMMUNITY; LYMPHOCYTE ACTIVATION; PNEUMOCOCCAL INFECTION; PRIORITY JOURNAL; QUESTIONNAIRE; REVIEW; RHEUMATOID ARTHRITIS; SEROCONVERSION; VIRUS STRAIN; VACCINATION;

HUMANS; INFLAMMATORY BOWEL DISEASES; VACCINATION; VACCINES;

EID: 70449701787     PISSN: 10780998     EISSN: 15364844     Source Type: Journal    
DOI: 10.1002/ibd.20941     Document Type: Review

References (66)

1. Hugot JP, Chamaillard M, Zouali H, et al. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature. 2001;411:599-603. (Pubitemid 32531408)
2. Ogura Y, Bonen DK, Inohara N, et al. A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature. 2001;411:603-606. (Pubitemid 32531409)
3. Baldassano RN, Bradfield JP, Monos DS, et al. Association of variants of the interleukin-23 receptor gene with susceptibility to pediatric Crohn's disease. Clin Gastroenterol Hepatol. 2007;5:972-976. (Pubitemid 47161140)
4. Duerr RH, Taylor KD, Brant SR, et al. A genome-wide association study identifies IL23R as an inflammatory bowel disease gene. Science. 2006;314:1461-1463. (Pubitemid 44871953)
5. Danese S, Fiocchi C. Etiopathogenesis of inflammatory bowel diseases. World J Gastroenterol. 2006;12:4807-4812.
6. Rufo PA, Bousvaros A. Current therapy of inflammatory bowel disease in children. Paediatr Drugs. 2006;8:279-302. (Pubitemid 44607534)
7. Aberra FN, Lichtenstein GR. Methods to avoid infections in patients with inflammatory bowel disease. Inflamm Bowel Dis. 2005;11:685-695. (Pubitemid 40961083)
8. Viget N, Vernier-Massouille G, Salmon-Ceron D, et al. Opportunistic infections in patients with inflammatory bowel disease: prevention and diagnosis. Gut. 2008;57:549-558.
9. Nguyen GC, Kaplan GG, Harris ML, et al. A national survey of the prevalence and impact of Clostridium difficile infection among hospitalized inflammatory bowel disease patients. Am J Gastroenterol. 2008;103:1443-1450.
10. Kishore J, Ghoshal U, Ghoshal UC, et al. Infection with cytomegalovirus in patients with inflammatory bowel disease: prevalence, clinical significance and outcome. J Med Microbiol. 2004;53(Pt 11):1155-1160. (Pubitemid 40052501)
11. Bhatia J, Bratcher J, Korelitz B, et al. Abnormalities of uterine cervix in women with inflammatory bowel disease. World J Gastroenterol. 2006;12:6167-6171.
12. Kane S, Khatibi B, Reddy D. Higher incidence of abnormal Pap smears in women with inflammatory bowel disease. Am J Gastroenterol. 2008;103:631-636.
13. Papadakis KA, Tung JK, Binder SW, et al. Outcome of cytomegalovirus infections in patients with inflammatory bowel disease. Am J Gastroenterol. 2001;96:2137-2142. (Pubitemid 32660910)
14. Posthuma EF, Westendorp RG, van der Sluys Veer A, et al. Fatal infectious mononucleosis: a severe complication in the treatment of Crohn's disease with azathioprine. Gut. 1995;36:311-313.
15. Francois-Dufresne A, Garbino J, Ricou B, et al. ARDS caused by herpes simplex virus pneumonia in a patient with Crohn's disease: a case report. Intensive Care Med. 1997;23:345-347. (Pubitemid 27130003)
16. Deutsch DE, Olson AD, Kraker S, et al. Overwhelming varicella pneumonia in a patient with Crohn's disease treated with 6-mercaptopurine. J Pediatr Gastroenterol Nutr. 1995;20:351-353.
17. Korelitz BI, Fuller SR, Warman JI, et al. Shingles during the course of treatment with 6-mercaptopurine for inflammatory bowel disease. Am J Gastroenterol. 1999;94:424-426. (Pubitemid 29084663)
18. Keane J, Gershon S, Wise RP, et al. Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent. N Engl J Med. 2001;345:1098-1104. (Pubitemid 34940777)
19. Galandiuk S, Davis BR. Infliximab-induced disseminated histoplasmosis in a patient with Crohn's disease. Nat Clin Pract Gastroenterol Hepatol. 2008;5:283-287. (Pubitemid 351637914)
20. Jain VV, Evans T, Peterson MW. Reactivation histoplasmosis after treatment with anti-tumor necrosis factor alpha in a patient from a nonendemic area. Respir Med. 2006;100:1291-1293. (Pubitemid 43793058)
21. Itaba S, Iwasa T, Sadamoto Y, et al. Pneumocystis pneumonia during combined therapy of infliximab, corticosteroid, and azathioprine in a patient with Crohn's disease. Dig Dis Sci. 2007;52:1438-1441. (Pubitemid 46776504)
22. Kaur N, Mahl TC. Pneumocystis jiroveci (carinii) pneumonia after infliximab therapy: a review of 84 cases. Dig Dis Sci. 2007;52:1481-1484.
23. Zignol M, Peracchi M, Tridello G, et al. Assessment of humoral immunity to poliomyelitis, tetanus, hepatitis B, measles, rubella, and mumps in children after chemotherapy. Cancer. 2004;101:635-641. (Pubitemid 38970616)
24. Chaves TS, Pereira LM, De Santos SS, et al. Evaluation of the vaccination status in pediatric renal transplant recipients. Pediatr Transplant. 2008;12:432-435. (Pubitemid 351652071)
25. Nachman S, Kim S, King J, et al. Safety and immunogenicity of a heptavalent pneumococcal conjugate vaccine in infants with human immunodeficiency virus type 1 infection. Pediatrics. 2003;112(1 Pt 1):66-73. (Pubitemid 36792931)
26. Rutstein RM, Rudy BJ, Cnaan A. Response of human immunodeficiency virus-exposed and -infected infants to Haemophilus influenzae type b conjugate vaccine. Arch Pediatr Adolesc Med. 1996;150:838-841. (Pubitemid 26269896)
27. Matsuzaki A, Suminoe A, Koga Y, et al. Immune response after influenza vaccination in children with cancer. Pediatr Blood Cancer. 2005;45:831-837. (Pubitemid 41416495)
28. Brydak LB, Roszkowska-Blaim M, Machala M, et al. Antibody response to influenza immunization in two consecutive epidemic seasons in patients with renal diseases. Vaccine. 2000;18:3280-3286. (Pubitemid 30408204)
29. Drachman R, Isacsohn M, Rudensky B, et al. Vaccination against hepatitis B in children and adolescent patients on dialysis. Nephrol Dial Transplant. 1989;4:372-374. (Pubitemid 19189337)
30. Pillion G, Chiesa M, Maisin A, et al. Immunogenicity of hepatitis B vaccine (HEVAC B) in children with advanced renal failure. Pediatr Nephrol. 1990;4:627-629.
31. Kano H, Mizuta K, Sakakihara Y, et al. Efficacy and safety of immunization for pre- and post-liver transplant children. Transplantation. 2002;74:543-550. (Pubitemid 34977687)
32. Weinberg A, Horslen SP, Kaufman SS, et al. Safety and immunogenicity of varicella-zoster virus vaccine in pediatric liver and intestine transplant recipients. Am J Transplant. 2006;6:565-568. (Pubitemid 43382144)
33. Schulman SL, Deforest A, Kaiser BA, et al. Response to measles-mumps-rubella vaccine in children on dialysis. Pediatr Nephrol. 1992;6:187-189.
34. Chalmers A, Scheifele D, Patterson C, et al. Immunization of patients with rheumatoid arthritis against influenza: a study of vaccine safety and immunogenicity. J Rheumatol. 1994;21:1203-1206. (Pubitemid 24234652)
35. Kubota T, Nii T, Nanki T, et al. Anti-tumor necrosis factor therapy does not diminish the immune response to influenza vaccine in Japanese patients with rheumatoid arthritis. Mod Rheumatol. 2007;17:531-533.
36. Fomin I, Caspi D, Levy V, et al. Vaccination against influenza in rheumatoid arthritis: the effect of disease modifying drugs, including TNF alpha blockers. Ann Rheum Dis. 2006;65:191-194. (Pubitemid 43131992)
37. Elkayam O, Ablin J, Caspi D. Safety and efficacy of vaccination against streptococcus pneumonia in patients with rheumatic diseases. Autoimmun Rev. 2007;6:312-314. (Pubitemid 46507995)
38. Jarrett MP, Schiffman G, Barland P, et al. Impaired response to pneumococcal vaccine in systemic lupus erythematosus. Arthritis Rheum. 1980;23:1287-1293. (Pubitemid 11234046)
39. Nies K, Boyer R, Stevens R, et al. Anti-tetanus toxoid antibody synthesis after booster immunization in systemic lupus erythematosus. Comparison of the in vitro and in vivo responses. Arthritis Rheum. 1980;23:1343-1350.
40. Abu-Shakra M, Press J, Varsano N, et al. Specific antibody response after influenza immunization in systemic lupus erythematosus. J Rheumatol. 2002;29:2555-2557. (Pubitemid 35416961)
41. Williams GW, Steinberg AD, Reinertsen JL, et al. Influenza immunization in systemic lupus eruthematosus. A double-blind trial. Ann Intern Med. 1978;88:729-734.
42. Battafarano DF, Battafarano NJ, Larsen L, et al. Antigen-specific antibody responses in lupus patients following immunization. Arthritis Rheum. 1998;41:1828-1834. (Pubitemid 28465537)
43. Kapetanovic MC, Saxne T, Nilsson JA, et al. Influenza vaccination as model for testing immune modulation induced by anti-TNF and methotrexate therapy in rheumatoid arthritis patients. Rheumatology (Oxford). 2007;46:608-611. (Pubitemid 46523304)
44. Kapetanovic MC, Saxne T, Sjoholm A, et al. Influence of methotrexate, TNF blockers and prednisolone on antibody responses to pneumococcal polysaccharide vaccine in patients with rheumatoid arthritis. Rheumatology (Oxford). 2006;45:106-111.
45. Sands BE, Cuffari C, Katz J, et al. Guidelines for immunizations in patients with inflammatory bowel disease. Inflamm Bowel Dis. 2004;10:677-692. (Pubitemid 39276481)
46. Melmed GY, Ippoliti AF, Papadakis KA, et al. Patients with inflammatory bowel disease are at risk for vaccine-preventable illnesses. Am J Gastroenterol. 2006;101:1834-1840. (Pubitemid 44166594)
47. Mamula P, Markowitz JE, Piccoli DA, et al. Immune response to influenza vaccine in pediatric patients with inflammatory bowel disease. Clin Gastroenterol Hepatol. 2007;5:851-856. (Pubitemid 47031059)
48. Lu Y, Jacobson DL, Ashworth LA, et al. Immune response to influenza vaccine in children with inflammatory bowel disease. Am J Gastroenterol. 2009;104:444-453.
49. Ye Z. Influenza vaccine responses. http://www.fda.gov/ohrms/dockets/ac/ 08/slides/2008-4348S2-5-files/frame.htm 2008.
50. Stevens R, Oliver M, Brogan M, et al. Defective generation of tetanus-specific antibody-producing B cells after in vivo immunization of Crohn's disease and ulcerative colitis patients. Gastroenterology. 1985;88:1860-1866. (Pubitemid 15052298)
51. Gelinck LB, van der Bijl AE, Beyer WE, et al. The effect of antitumour necrosis factor alpha treatment on the antibody response to influenza vaccination. Ann Rheum Dis. 2008;67:713-716.
52. Melmed G. TNF blockers and immunomodulators impair antibody responses to pneumococcal polysaccharide vaccine in patients with inflammatory bowel disease. Gastroenterology. 2008;134:Abstract S1 A68.
53. Cytomegalovirus Infection. Red Book: 2006 Report of the Committee on Infectious Diseases, 27th ed. In: Pickering L, Baker CJ, Long SS, McMillan JA, editors. Elk Grove Village, IL: American Academy of Pediatrics; 2006. p 273-277
54. Epstein-Barr Virus Infections. Red Book: 2006 Report of the Committee on Infectious Diseases, 27th ed. In: Pickering L, Baker CJ, Long SS, McMillan JA, editors. Elk Grove Village, IL: American Academy of Pediatrics; 2006. p 286-288.
55. CDC. Epstein-Barr Virus and Infectious Mononucleosis. At: http://www.cdc.gov/ncidod/diseases/ebv.htm; 2008.
56. Hepatitis B. Red Book: 2006 Report of the Committee on Infectious Diseases, 27th ed. In: Pickering L, Baker CJ, Long SS, McMillan JA, editors. Elk Grove Village, IL: American Academy of Pediatrics; 2006. p 335-355.
57. Herpes simplex. Red Book: 2006 Report of the Committee on Infectious Diseases, 27th ed. In: Pickering L, Baker CJ, Long SS, McMillan JA, editors. Elk Grove Village, IL: American Academy of Pediatrics; 2006. p 361-371.
58. Influenza. Red Book: 2006 Report of the Committee on Infectious Diseases, 27th ed. In: Pickering L, Baker CJ, Long SS, McMillan JA, editors. Elk Grove Village, IL: American Academy of Pediatrics; 2006. p 401-411.
59. CDC. Influenza Antiviral Medications: Summary for Clinicians At: http://www.cdc.gov/flu/professionals/antivirals/summary-clinicians.htm; 2008.
60. Varicella-Zoster Infections. Red Book: 2006 Report of the Committee on Infectious Diseases, 27th ed. In: Pickering L, Baker CJ, Long SS, McMillan JA, editors. Elk Grove Village, IL: American Academy of Pediatrics; 2006. p 711-725.
61. Human Papillomaviruses. Red Book: 2006 Report of the Committee on Infectious Diseases, 27th ed. In: Pickering L, Baker CJ, Long SS, McMillan JA, editors. Elk Grove Village, IL: American Academy of Pediatrics; 2006. p 473-477.
62. CDC. Human Papillomavirus (HPV) Infection. At: http://www.cdc. gov/STD/HPV; 2008.
63. Clostridium difficile. Red Book: 2006 Report of the Committee on Infectious Diseases, 27th ed. In: Pickering L, Baker CJ, Long SS, McMillan JA, editors. Elk Grove Village, IL: American Academy of Pediatrics; 2006. p 261-263.
64. Tuberculosis. Red Book: 2006 Report of the Committee on Infectious Diseases, 27th ed. In: Pickering L, Baker CJ, Long SS, McMillan JA, editors. Elk Grove Village, IL: American Academy of Pediatrics; 2006. p 678-698.
65. Histoplasmosis. Red Book: 2006 Report of the Committee on Infectious Diseases, 27th ed. In: Pickering L, Baker CJ, Long SS, McMillan JA, editors. Elk Grove Village, IL: American Academy of Pediatrics; 2006. p 371-374.
66. Pneumocystis jiroveci Infections. Red Book: 2006 Report of the Committee on Infectious Diseases, 27th ed. In: Pickering L, Baker CJ, Long SS, McMillan JA, editors. Elk Grove Village, IL: American Academy of Pediatrics; 2006. p 537-542.